Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery

NCT01181141 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: DU-176b (edoxaban)
DRUG: Enoxaparin sodium 20mg

Sponsor

Daiichi Sankyo Co., Ltd.